Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis.
Boulaftali Y, Ho-Tin-Noe B, Pena A, Loyau S, Venisse L, François D, Richard B, Arocas V, Collet JP, Jandrot-Perrus M, Bouton MC. Boulaftali Y, et al. Among authors: francois d. Circulation. 2011 Mar 29;123(12):1326-34. doi: 10.1161/CIRCULATIONAHA.110.000885. Epub 2011 Mar 14. Circulation. 2011. PMID: 21403095 Free PMC article.
Protease nexin-1 regulates retinal vascular development.
Selbonne S, Francois D, Raoul W, Boulaftali Y, Sennlaub F, Jandrot-Perrus M, Bouton MC, Arocas V. Selbonne S, et al. Among authors: francois d. Cell Mol Life Sci. 2015 Oct;72(20):3999-4011. doi: 10.1007/s00018-015-1972-5. Epub 2015 Jun 25. Cell Mol Life Sci. 2015. PMID: 26109427 Free PMC article.
Novel ELISA for the specific detection of protease NEXIN-1 in human biological samples.
Venisse L, François D, Madjène C, Brouwers E, de Raucourt E, Boulaftali Y, Declerck P, Arocas V, Bouton MC. Venisse L, et al. Among authors: francois d. Res Pract Thromb Haemost. 2022 Jul 19;6(5):e12756. doi: 10.1002/rth2.12756. eCollection 2022 Jul. Res Pract Thromb Haemost. 2022. PMID: 35865733 Free PMC article.
Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition.
Billiald P, Slater A, Welin M, Clark JC, Loyau S, Pugnière M, Jiacomini IG, Rose N, Lebozec K, Toledano E, François D, Watson SP, Jandrot-Perrus M. Billiald P, et al. Among authors: francois d. Blood Adv. 2023 Apr 11;7(7):1258-1268. doi: 10.1182/bloodadvances.2022007863. Blood Adv. 2023. PMID: 36375047 Free PMC article.
Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial.
Pottecher J, Raffi F, Jandrot-Perrus M, Binay S, Comenducci A, Desort-Henin V, François D, Gharakhanian S, Labart M, Meilhoc A, Toledano E, Pletan Y, Avenard G, Sato VH; GARDEN Investigators. Pottecher J, et al. Among authors: francois d. PLoS One. 2024 Jun 17;19(6):e0302897. doi: 10.1371/journal.pone.0302897. eCollection 2024. PLoS One. 2024. PMID: 38885234 Free PMC article. Clinical Trial.
190 results